Pierre Beaurang hits the ground running at his 3rd startup; Mike Grey poaches Astellas dealmaker to head protein degradation player

Pierre Beaurang

As Nitrome Biosciences — a biotech founded in 2017 to focus on a class of enzymes called nitrases — rebrands to Nitrase Therapeutics, the company is also bringing on a new CEO: Pierre Beaurang.

In Nitrase’s statement earlier this week announcing its new CEO,...

Click to view original post